Current Report Filing (8-k)
September 07 2017 - 5:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 31, 2017
MEDICINOVA, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
DELAWARE
|
|
001-33185
|
|
33-0927979
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
4275 EXECUTIVE SQUARE,
SUITE 650, LA JOLLA, CA
|
|
92037
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (858)
373-1500
Check the
appropriate box below if the
Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2.
below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to
Rule 14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to
Rule 14d-2(b) under
the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to
Rule 13e-4(c) under
the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule
12b-2
of the Securities Exchange Act of 1934 (17 CFR
§240.12b-2).
Emerging growth
company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01.
|
Entry into a Material Definitive Agreement.
|
On August 31, 2017, MediciNova, Inc. (the
Company) entered into a sublease agreement (the Sublease) with Cardinal Health 127 Inc. (the Sublessor) for certain premises located at 4275 Executive Square, Suite 300, La Jolla, California, consisting of
approximately 4,400 square feet. The term of the Sublease commences on December 1, 2017 and ends on December 31, 2021. The Sublease was consented to by the master lessor. The Sublease provides that the Company will pay the Sublessor a
monthly basic rent commencing with $10,958 per month with annual escalators thereafter, other than $5,479 per month for months two through five of the Sublease.
The foregoing description of the Sublease is qualified in its entirety by reference to the Sublease, which is filed as Exhibit 10.1 to this Current Report and
incorporated herein by reference.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits
|
|
|
Exhibit
Number
|
|
Description
|
|
|
10.1
|
|
Sublease, by and between the Company and Cardinal Health 127 Inc., dated August 31, 2017.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
MEDICINOVA, INC.
|
|
|
|
|
DATE: September 7, 2017
|
|
|
|
By:
|
|
/s/ Ryan Selhorn
|
|
|
|
|
|
|
Ryan Selhorn
|
|
|
|
|
|
|
Chief Financial Officer
|
Exhibit Index
Medicinova (NASDAQ:MNOV)
Historical Stock Chart
From Apr 2024 to May 2024
Medicinova (NASDAQ:MNOV)
Historical Stock Chart
From May 2023 to May 2024